Practical considerations for managing patients with diabetes and dementia

References

• Cowie C, Rust KF, Ford ES, et al. Full accounting of diabetes and pre-diabetes in the U.S. Population in 1988–1994 and 2005–2006. Diabetes Care. 2009;32:287–294.
   PubMed Web of Science ®Google Scholar
• Whiting D, Guairquata L, Shaw J. International Diabetes Federation (IDF) Global estimates of prevalence of diabetes for 2011–2030. Diabetes Res Clin Pract. 2013;44:311–321.
   Google Scholar
• Arvanitakis Z, Wilson RS, Bienias JL, et al. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol. 2004;61:661–666.
   PubMed Web of Science ®Google Scholar
• Luchsinger JA, Reitz C, Patel B, et al. Relation of diabetes to mild cognitive impairment. Arch Neurol. 2007;64:570–575.
   PubMed Web of Science ®Google Scholar
• Ahtiluoto S, Polvikoski T, Peltonen M, et al. Diabetes, Alzheimer disease and vascular dementia: a population-based neuropathologic study. Neurology. 2010;75:1195–1202.
   PubMed Web of Science ®Google Scholar
• Ricci P, Blotière PO, Weill A, et al. Diabète traité en France: quelles évolutions entre 2000 et 2009? Bull Epidemiol Hebd. 2010;43:425–431.
   Google Scholar
• Resnick HE, Heineman J, Stone R, et al. Diabetes in US nursing homes, 2004. Diabetes Care. 2008;31:287–288.
   PubMed Web of Science ®Google Scholar
• Dybicz SB, Thompson S, Molotsky S, et al. Prevalence of diabetes and the burden of comorbid conditions among elderly nursing home residents. Am J Geriatr Pharmacother. 2011;9:212–223.
   PubMedGoogle Scholar
• Feil DG, Rajan M, Soroka O, et al. Risk of hypoglycemia in older veterans with dementia and cognitive impairment: implications for practice and policy. J Am Geriatr Soc. 2011;59:2263–2272.
   PubMed Web of Science ®Google Scholar
• Thorpe CT, Thorpe JM, Kind AJ, et al. Receipt of monitoring of diabetes mellitus in older adults with comorbid dementia. J Am Geriatr Soc. 2012;60:644–651.
   PubMed Web of Science ®Google Scholar
• Bordier L, Doucet J, Boudet J, et al. Update on cognitive decline and dementia in elderly patients with diabetes. Diabetes Metab. 2014;40:331–337.
   PubMed Web of Science ®Google Scholar
• Gadsby R, Barker P, Sinclair A. People living with diabetes resident in nursing homes–assessing levels of disability and nursing needs. Diabet Med. 2011;28:778–780.
   PubMed Web of Science ®Google Scholar
• Kirkman MS, Briscoe VJ, Clark N, et al. Diabetes in older adults. Diabetes Care. 2012;35:2650–2664.
   PubMed Web of Science ®Google Scholar
• Greco D, Pisciotta M, Gambina F, et al. Severe hypoglycaemia leading to hospital admission in type 2 diabetic patients aged 80 years or older. Exp Clin Endocrinol Diabetes. 2010;118:215–219.
   PubMed Web of Science ®Google Scholar
• Geller AI, Shehab N, Lovegrove MC, et al. National estimates of insulin-related hypoglycemia and errors leading to emergency department visits and hospitalizations. JAMA Intern Med. 2014;174:678–686.
   PubMed Web of Science ®Google Scholar
• Guariguata L, Nolan T, Beagley J, et al. International Diabetes Federation diabetes atlas. Brussels: International Diabetes Federation; 2014.
   Google Scholar
• Thies W, Bleiler L, Alzheimer’s Association. Alzheimer’s disease facts and figures. Alzheimer Dement. 2013;9:208–245.
   PubMed Web of Science ®Google Scholar
• Roberts RO, Knopman DS, Geda YE, et al. Association of diabetes with amnestic and non-amnestic mild cognitive impairment. Alzheimers Dement. 2014;10:18–26.
   PubMed Web of Science ®Google Scholar
• Li J, Wang YJ, Zhang M, et al.; the Chongqing Ageing Study Group. Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease. Neurology. 2011;76:1485–1491.
   PubMed Web of Science ®Google Scholar
• Cheng G, Huang C, Deng H, et al. Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Intern Med J. 2012;42:484–491.
   PubMed Web of Science ®Google Scholar
• Diabetes Mellitus NT. Dementia. Curr Diab Rep. 2014;14:487.
   PubMed Web of Science ®Google Scholar
• Gudala K, Bansal D, Schifano F, et al. Diabetes mellitus and risk of dementia: a meta-analysis of prospective observational studies. J Diabetes Investig. 2013;4:640–650.
   PubMed Web of Science ®Google Scholar
• Whitmer RA, Biessels GJ, Quesenberry CP, et al. Type 1 diabetes and risk of dementia in late life: the Kaiser Diabetes & Cognitive Aging Study. Alzheimer’s and Dementia. 2015;11(Suppl.):179–180.
   Google Scholar
• Rawlings AM, Sharrett AR, Schneider ALC, et al. Diabetes in midlife and cognitive change over 20 years: the Atherosclerosis Risk in Communities Neurocognitive Study. Ann Intern Med. 2014;161:785–793.
   PubMed Web of Science ®Google Scholar
• Twig G, Gluzman I, Tirosh A, et al. Cognitive function and the risk for diabetes among young men. Diabetes Care. 2014;37:2982–2988.
   PubMed Web of Science ®Google Scholar
• Frisardi V, Solfrizzi V, Capurso C, et al. Is insulin resistant brain state a central feature of the metabolic cognitive syndrome? J Alzheimers Dis. 2010;21:57–63.
   PubMed Web of Science ®Google Scholar
• De La Monte SM. Insulin resistance and Alzheimer’s disease. BMB Re. 2009;42:475–481.
   PubMed Web of Science ®Google Scholar
• Moreno-Gonzalez I, Edwards III G, Salvadores N, et al. Molecular interaction between type 2 diabetes and Alzheimer’s disease through cross-seeding of protein misfolding. Mol Psychiatry. 2017. DOI:10.1038/mp.2016.230.
   Web of Science ®Google Scholar
• Akter K, Lanza EA, Martin SA, et al. Diabetes mellitus and Alzheimer’s disease: shared pathology and treatment? Brit J Clin Pharmacol. 2011;71:365–376.
   PubMed Web of Science ®Google Scholar
• Passaro A, Nora ED, Morieri ML, et al. Brain-derived neurotrophic factor plasma levels: relationship with dementia and diabetes in the elderly population. J Gerontol A Biol Sci Med Sci. 2015;70:294–302.
   PubMed Web of Science ®Google Scholar
• Middleton LE, Yaffe K. Promising strategies for the prevention of dementia. Arch Neurol. 2009;66:1210–1215.
   PubMed Web of Science ®Google Scholar
• Crane PK, Walker R, Hubbard RA, et al. Glucose levels and risk of dementia. N Engl J Med. 2013;369:540–548.
   PubMed Web of Science ®Google Scholar
• Kerti L, Witte AV, Winkler A, et al. Higher glucose levels associated with lower memory and reduced hippocampal microstructure. Neurology. 2013;81:1746–1752.
   PubMed Web of Science ®Google Scholar
• Feinkohl I, Aung PP, Keller M, et al. Severe hypoglycemia and cognitive decline in older people with type 2 diabetes: the edinburgh type 2 diabetes study. Diabetes Care. 2014;37:507–515.
   PubMed Web of Science ®Google Scholar
• Lin CH, Sheu WHH. Hypoglycaemic episodes and risk of dementia in diabetes mellitus: 7-year follow-up study. J Intern Med. 2013;273:102–110.
   PubMed Web of Science ®Google Scholar
• Takeda M, Martinez R, Kudo T, et al. Apolipoprotein E and central nervous systemdisorders: reviews of clinical findings. Psychiatry Clin Neurosci. 2010;64:592–607.
   PubMed Web of Science ®Google Scholar
• Lu ZK, Li M, Yuan J, et al. The role of cerebrovascular disease and the association between diabetes mellitus and dementia among aged Medicare beneficiaries. Int J Geriatr Psychiatry. 2016;31:92–98.
   PubMed Web of Science ®Google Scholar
• Bangen KJ, Gu Y, Gross AL, et al. Relationship between type 2 diabetes mellitus and cognitive change in a multi-ethnic elderly cohort. J Am Geriatr Soc. 2015;63:1075–1083.
   PubMed Web of Science ®Google Scholar
• Araki A, Yoshimura Y, Sakurai T, et al. Low intakes of carotene, vitaminB2, pantothenate and calcium predict cognitive decline among elderly patients with diabetes mellitus: the Japanese Elderly Diabetes Intervention Trial. Geriatr Gerontol Int. 2016. DOI:10.1111/ggi.12843.
   Google Scholar
• Batty GD, Li Q, Huxley R, et al. Oral disease in relation to future risk of dementia and cognitive decline: prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trial. European Psychiatry. 2013;28:49–52.
   PubMed Web of Science ®Google Scholar
• Janelidze S, Hertze J, Nägga K, et al. Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype. Neurobiol Aging. 2017;51:104–112.
   PubMed Web of Science ®Google Scholar
• Reijmer YD, Van Den BE, Ruis C, et al. Cognitive dysfunction in patients with type 2 diabetes. Diabetes Metab Res Rev. 2010;26:507–519.
   PubMed Web of Science ®Google Scholar
• van den Berg E, Reijmer YD, de Bresser J, et al. A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus. Diabetologia. 2010;53:58–65.
   PubMed Web of Science ®Google Scholar
• Moyer VA on behalf of the U.S. Preventive Services Task Force. Screening for Cognitive Impairment in Older Adults: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 2014;160:791–797.
   Google Scholar
• Feil DG, Zhu CW, Sultzer DL. The relationship between cognitive impairment and diabetes self-management in a population-based community sample of older adults with type 2 diabetes. J Behav Med. 2012;35:190–199.
   PubMed Web of Science ®Google Scholar
• Feil DG, Pearman A, Victor T, et al. The role of cognitive impairment and caregiver support in diabetes management of older outpatients. Int J Psychiatry Med. 2009;39:199–214.
   PubMed Web of Science ®Google Scholar
• deWet H, Levitt N, Tipping B. Executive cognitive impairment detected by simple bedside testing is associated with poor glycaemic control in type 2 diabetes. S Afr Med J. 2007;97:1074–1076.
   PubMed Web of Science ®Google Scholar
• Tomlin A, Sinclair A. The influence of cognition on self-management of type 2 diabetes in older people. Psychol Res Behav Manag. 2016;9:7–20.
   PubMed Web of Science ®Google Scholar
• Koekkoek PS, Kappelle LJ, van den Berg E, et al. Cognitive function in patients with diabetes mellitus: guidance for daily care. Lancet Neurol. 2015;14:329–340.
   PubMed Web of Science ®Google Scholar
• Mattishent K, Loke YK. Bi-directional interaction between hypoglycaemia and cognitive impairment in elderly patients treated with glucose-lowering agents: a systematic review and meta-analysis. Diabetes Obes Metab. 2016;18:135–141.
   PubMed Web of Science ®Google Scholar
• Abbatecola AM, Bo M, Barbagallo M, et al. Severe hypoglycemia is associated with anti-diabetic oral treatment compared with insulin analogs in nursing home patients with type 2 diabetes and dementia: results from the DIMORA study. J Am Med Dir Assoc. 2015;16:349 e7–349.e12.
   PubMed Web of Science ®Google Scholar
• Prinz N, Stingl J, Dapp A, et al. High rate of hypoglycemia in 6770 type 2 diabetes patients with comorbid dementia: A multicenter cohort study on 215,932 patients from the German/Austrian diabetes registry. Diabetes Res Clin Pract. 2016;112:73–81.
   PubMed Web of Science ®Google Scholar
• The ORIGIN Trial Investigators. Predictors of Non-severe and Severe Hypoglycemia During Glucose-Lowering Treatment With Insulin Glargine or Standard Drugs in the ORIGIN Trial. Diabetes Care. 2015;38:22–28.
   Google Scholar
• Yaffe K, Falvey CM, Hamilton N, et al.; for the Health ABC Study. Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus. JAMA Intern Med. 2013;173:1300–1306.
   PubMed Web of Science ®Google Scholar
• De Galan BE, Zoungas S, Chalmers I, et al. Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the action in diabetes and vascular disease: preterax and diamicron modified release controlled evaluation (ADVANCE) trial. Diabetologia. 2009;52:1336–2328.
   Web of Science ®Google Scholar
• Punthakee Z, Miller ME, Launer LJ, et al. Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes- post hoc epidemiologic analysis of the ACCORD trial. Diabetes Care. 2012;35:787–793.
   PubMed Web of Science ®Google Scholar
• Bruce DG, Davis WA, Casey GP, et al. Severe hypoglycemia and cognitive impairment in older patients with diabetes: the fremantle diabetes study. Diabetologia. 2009;52:1808–1815.
   PubMed Web of Science ®Google Scholar
• Bergman H, Ferrucci L, Guralnik J, et al. Frailty: an emerging research and clinical paradigm-issues and controversies. J Gerontol A Biol Sci Med Sci. 2009;62A:731–737.
   Google Scholar
• Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56A:M146–M56.
   Web of Science ®Google Scholar
• Lee JSW, Auyeung TW, Leung J, et al. The effect of diabetes mellitus on age-associated lean mass loss in 3153 older adults. Diabet Med. 2010;27:1366–1371.
   PubMed Web of Science ®Google Scholar
• Castrejón-Pérez RC, Gutiérrez-Robledo LM, Cesari M, et al. Diabetes mellitus, hypertension and frailty: A population-based, cross-sectional study of Mexican older adults. Geriatr Gerontol Int. 2017;17:925–930.
   PubMed Web of Science ®Google Scholar
• Lee S, S L, Harada K, et al. Relationship between chronic kidney disease with diabetes or hypertension and frailty in community-dwelling Japanese older adults. Geriatr Gerontol Int. 2016. DOI:10.1111/ggi.12910.
   Google Scholar
• Searle SD, Rockwood K. Frailty and the risk of cognitive impairment. Alzheimers Res Ther. 2015;7:54.
   PubMed Web of Science ®Google Scholar
• Lafortune L, Martin S, Kelly S, et al. Behavioural risk factors in mid-life associated with successful ageing, disability, dementia and frailty in later life: a rapid systematic review. PLoS ONE. 2016;11:e0144405.
   PubMed Web of Science ®Google Scholar
• Buchman AS, Yu L, Wilson RS, et al. Association of brain pathology with the progression of frailty in older adults. Neurology. 2013;80:1–7.
   Web of Science ®Google Scholar
• Fukazawa R, Hanyu H, Sato T, et al. Subgroups of Alzheimer’s disease associated with diabetes mellitus based on brain imaging. Dement Geriatr Cogn Disord. 2013;35:280–290.
   PubMed Web of Science ®Google Scholar
• Hirose D, Hanyu H, Fukasawa R, et al. Frailty in diabetes-related dementia. Geriatr Gerontol Int. 2016. DOI:10.1111/ggi.12566.
   Web of Science ®Google Scholar
• Kojima G, Taniguchi Y, Iliffe S, et al. Frailty as a predictor of Alzheimer disease, vascular dementia, and all dementia among community-dwelling older people: a systematic review and meta-analysis. J Am Med Dir Assoc. 2016;17:881–888.
   PubMed Web of Science ®Google Scholar
• Kelaiditi E, Cesari M, Canevelli M, et al. Cognitive frailty: rational and definition from an (IANA/IAGG) international consensus group. J Nutr Health Aging. 2013;17:726–734.
   PubMed Web of Science ®Google Scholar
• Kovesdy CP, Park JC, Kalantar-Zadeh K. Glycemic control and burnt-out diabetes in ESRD. Semin Dial. 2010;23:148–156.
   PubMed Web of Science ®Google Scholar
• Whitmer RA, Karter AJ, Yaffe K, et al. Hypoglycemic episodes and risk ofdementia in older patients with type 2 diabetes mellitus. JAMA. 2009;301:1565–1572.
   Google Scholar
• Abdelhafiz AH, McNicholas E, Sincalir AJ. Hypoglycemia, frailty and dementia in older people with diabetes: reciprocal relations and clinical implications. J Diabetes Complications. 2016;30:1548–1554.
   PubMed Web of Science ®Google Scholar
• Sussman J, Kerr EA, Saini SD, et al. Rates of deintensification of blood pressure and glycemic medication treatment based on levels of control and life expectancy in older patients with diabetes mellitus. JAMA Intern Med. 2015;175:1942–1949.
   PubMed Web of Science ®Google Scholar
• Caverly TJ, Fagerlin A, Zikmund-Fisher BJ, et al. Appropriate prescribing for patients with diabetes at high risk for hypoglycemia: national survey of veterans affairs health care professionals. JAMA Intern Med. 2015;175:1994–1996.
   PubMed Web of Science ®Google Scholar
• Sinclair A, Armes DG, Randhawa G, et al. Caring for older adults with diabetes mellitus: characteristics of carers and their prime roles and responsibilities. Diabet Med. 2010;27:1055–1059.
   PubMed Web of Science ®Google Scholar
• Sinclair AJ, Gadsby R, Hillson R, et al. Brief report: use of the Mini-Cog as a screening tool for cognitive impairment in diabetes in primary care. Diabetes Res Clin Pract. 2013;100:23–25.
   Web of Science ®Google Scholar
• Jaap A, Jones G, McCrimmon R, et al. Perceived symptoms of hypoglycemia in elderly type 2 diabetic patients treated with insulin. Diabet Med. 1998;15:398–401.
   PubMed Web of Science ®Google Scholar
• Abdelhafiz AH, Bailey C, Loo BE, et al. Hypoglycemic symptoms and hypoglycemia threshold in older people with diabetes-a patient perspective. J Nutr Health Aging. 2013;17:899–902.
   PubMed Web of Science ®Google Scholar
• Bonds DE, Miller ME, Dudl J, et al. Severe hypoglycemia symptoms, antecedent behaviors, immediate consequences and association with glycemia medication usage: secondary analysis of the ACCORD clinical trial data. BMC Endocrine Disorders. 2012;12. DOI:10.1186/1472-6823-12-5.
   PubMed Web of Science ®Google Scholar
• Lee JSW, Auyeung TW, Leung J, et al. Transitions in frailty states among community-living older adults and their associated factors. J Am Med Dir Assoc. 2014;15:281–286.
   PubMed Web of Science ®Google Scholar
• Morley JE, Malmstrom TK, Miller DK. A simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans. J Nutr Health Aging. 2012;16:601–608.
   PubMed Web of Science ®Google Scholar
• Cheng C, Lin CH, Tsai YW, et al. Type 2 diabetes and antidiabetic medications in relation to dementia diagnosis. J Gerontol A Biol Sci Med Sci. 2014;69:1299–1305.
   PubMed Web of Science ®Google Scholar
• Hanyu H, Sato T, Kiuchi A, et al. Pioglitazone improved cognition in a pilot study on patients with Alzheimer’s disease and mild cognitive impairment with diabetes mellitus. J Am Geriatr Soc. 2009;57:177–179.
   PubMed Web of Science ®Google Scholar
• Sato T, Hanyu H, Hirao K, et al. Efficacy of PPAR-gamma agonist pioglitazone in mild Alzheimer disease. Neurobiol Aging. 2011;32:1626–1633.
   PubMed Web of Science ®Google Scholar
• Heneka MT, Fink A, Doblhammer G. Effect of pioglitazone medication on the incidence of dementia. Ann Neurol. 2015;78:284–294.
   PubMed Web of Science ®Google Scholar
• Cheng H, Shang Y, Jiang L, et al. The peroxisome proliferators activated receptor-gamma agonists as therapeutics for the treatment of Alzheimer’s disease and mild-to-moderate Alzheimer’s disease: a meta-analysis. Int J Neurosci. 2016;126:299–307.
   PubMed Web of Science ®Google Scholar
• Liu J, Wang LN, Jia JP. Peroxisome proliferator-activated receptor-gamma agonists for Alzheimer’s disease and amnestic mild cognitive impairment: a systematic review and metaanalysis. Drugs Aging. 2015;32:57–65.
   PubMed Web of Science ®Google Scholar
• Hsu CC, Wahlqvist ML, Lee MS, et al. Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin. J Alzheimers Dis. 2011;24:485–493.
   PubMed Web of Science ®Google Scholar
• Gasparini L, Gouras GK, Wang R, et al. Stimulation of β-amyloid precursor protein trafficking by insulin reduces intraneuronal β-amyloid and requires mitogen-activated protein kinase signaling. J Neurosci. 2001;21:2561–2570.
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhou K, Wang R, et al. Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer’s amyloid peptides via up-regulating BACE1 transcription. Proc Natl Acad Sci USA. 2009;106:3907–3912.
   PubMed Web of Science ®Google Scholar
• Mcclean PL, Parthsarathy V, Faivre E, et al. The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer’s disease. J Neurosci. 2011;31:6587–6594.
   PubMed Web of Science ®Google Scholar
• Lipska K, Krumholz H, Soones T, et al. Polypharmacy in the aging patient. A review of glycemic control in older adults with type 2 diabetes. JAMA. 2016;315:1034–1045.
   Google Scholar
• Huang ES, Zhang Q, Gandra N, et al. The effect of comorbid illness and functional status on the expected benefits of intensive glucose control in older patients with type 2 diabetes: a decision analysis. Ann Intern Med. 2008;149:11–19.
   PubMed Web of Science ®Google Scholar
• Cox DJ, Kovatchev BP, Gonder-Frederick LA, et al. Relationships between hyperglycemia and cognitive performance among adults with type 1 and type 2 diabetes. Diabetes Care. 2005;28:71–77.
   PubMed Web of Science ®Google Scholar
• Lee SJ, Eng C. Goals of glycemic control in frail older patients with diabetes. JAMA. 2011;305:1350–1351.
   Google Scholar
• McCoy RG, Lipska KJ, Yao X, et al. Intensive treatment and severe hypoglycemia among adults with type 2 diabetes. JAMA Intern Med. 2016;176:969–978.
   PubMed Web of Science ®Google Scholar
• Abdelhafiz AH, Sinclair AJ. Hypoglycaemia in residential care homes. Br J Gen Pract. 2009;59:49–50.
   PubMed Web of Science ®Google Scholar
• Munshi MD, Slyne C, Segal AR, et al. Liberating A1C goals in older adults may not protect against the risk of hypoglycaemia. J Diabetes Complications. 2017;31:1197–1199.
   PubMed Web of Science ®Google Scholar
• Malanda UL, Welschen LMC, Riphagen II, et al. Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin. Cochrane Database Syst Rev. 2012;1:CD005060.
   PubMedGoogle Scholar
• Munshi MN, Slyne C, Segal AR, et al. Simplification of insulin regimen in older adults and risk of hypoglycemia. JAMA Intern Med. 2016;176:1023–1025.
   PubMed Web of Science ®Google Scholar
• Sjoblom P, Tengblad A, Lofgren UB, et al. Can diabetes medication be reduced in elderly patients? An observational study of diabetes drug withdrawal in nursing home patients with tight glycaemic control. Dib Res Clin Pract. 2008;82:197–202.
   PubMed Web of Science ®Google Scholar
• Abdelhafiz AH, Chakravorty P, Gupta S, et al. Can hypoglycaemic medications be withdrawn in older people with type 2 diabetes? Int J Clin Pract. 2014;68:790–792.
   PubMedGoogle Scholar
• Yoon JW, Ha YC, Kim KM, et al. Hyperglycemia is associated with impaired muscle quality in older men with diabetes: the Korean longitudinal study on health and aging. Diabetes Metab J. 2016;40:140–146.
   PubMed Web of Science ®Google Scholar
• García-Esquinas E, Graciani A, Guallar-Castillón P, et al. Diabetes and risk of frailty and its potential mechanisms: a prospective cohort study of older adults. J Am Med Dir Assoc. 2015;16:748–754.
   PubMed Web of Science ®Google Scholar
• Bauer JM, Biolo G, Cederlolm T, et al. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROTAGE study group. J Am Med Dir Assoc. 2013;14:542–559.
   PubMed Web of Science ®Google Scholar
• Bauer JM, Verlaan S, Bautmans I, et al. Effects of a vitamin D and leucine enriched whey protein nutritional supplement on measures of sarcopenia in older adults, the PROVIDE study: a randomized, double-blind, placeobo-controlled trial. J Am Med Dir Assoc. 2015;16:740–747.
   PubMed Web of Science ®Google Scholar
• Rahi B, Morais JA, Dionne IJ, et al. The combined effects of diet quality and physical activity on maintenance of muscle strength among diabetic older adults from the NuAge cohort. Exp Gerontol. 2014;49:40–46.
   PubMed Web of Science ®Google Scholar
• Rejeski WJ, Ip EH, Bertoni AG, et al.; Look AHEAD Research Group. Life style change and mobility in obese adults with type 2 diabetes. N Engl J Med. 2012;366:1209–1217.
   PubMed Web of Science ®Google Scholar
• Ngandu T, Lehtisalo J, Solomon A, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): A randomised controlled trial. Lancet. 2015;385:2255–2263.
   PubMed Web of Science ®Google Scholar
• Banerjee S. Multimorbidity—older adults need health care that can count past one. Lancet. 2015;385:587–589.
   PubMed Web of Science ®Google Scholar
• Strizich G, Kaplan RC, Gonzalez HM, et al. Glycemic control, cognitive function, and family support among middle-aged and older hispanics with diabetes: the Hispanic Community Health Study/Study of Latinos. Diabetes Res Clin Pract. 2016;117:64–73.
   PubMed Web of Science ®Google Scholar
• Okura T, Heisler M, Langa KM. Association between cognitive function and social support with glycemic control in adults with diabetes mellitus. J Am Geriatric Soc. 2009;57:1816–1824.
   PubMed Web of Science ®Google Scholar
• Bunn F, Burn AM, Goodman C, et al. Comorbidity and dementia: a scoping review of the literature. BMC Med. 2014;12:192.
   PubMed Web of Science ®Google Scholar
• Bunn F, Burn AM, Robinson L, et al. Healthcare organisation and delivery for people with dementia and comorbidity: a qualitative study exploring the views of patients, carers and professionals. BMJ Open. 2017;7:e013067.
   Web of Science ®Google Scholar
• Worrall G. Retrospective cohort study of mortality and hospitalization. Can Fam Physician. 2011;57:e16–e20.
   PubMed Web of Science ®Google Scholar
• Tattersall R, Simon P. Managing diabetes in residential and nursing homes: presents a complex set of problems with no one solution. BMJ. 1998;316:89.
   Google Scholar
• Wilson C, Curtis J, Lipke S, et al. Nurse case manager effectiveness and case load in a large clinical practice: implications for workforce development. Diabet Med. 2005;22:1116–1120.
   PubMed Web of Science ®Google Scholar
• Courtney M, Edwards H, Chang A, et al. Fewer emergency readmissions and better quality of life for older adults at risk of hospital readmission: a randomized controlled trial to determine the effectiveness of a 24-week exercise and telephone follow-up program. J Am Geriatr Soc. 2009;57:395–402.
   PubMed Web of Science ®Google Scholar
• Rosentock J, Daily G, Massi-Benedetti M, et al. Reduced hypoglycaemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes. Diabetes Care. 2005;28:950–956.
   PubMed Web of Science ®Google Scholar
• McAiney CA, Haughton D, Jennings J, et al. A unique practice model for nurse practitioners in long-term care homes. J Adv Nurs. 2008;62:562–571.
   PubMed Web of Science ®Google Scholar
• Sinclair AJ. task and finish group of diabetes UK. Good clinical practice guidelines for care home residents with diabetes: an executive summary. Diabet Med. 2011;28:772–777.
   PubMed Web of Science ®Google Scholar